Information: This is an outdated version of the data model. You can find a Versions overview via Versions on the left. You can find the newest Version by clicking here.
Information:
Error:
ID
12666
Description
MIPSO Comparative study of bacterial microbiota in the skin and intestines of psoriasis patients before and after systemic treatment with adalimumab or ustekinumab or ciclosporin (EudraCT 2014-003022-40) Principal Investigator: Prof. Dr. Dr. H. C. Thomas A. Luger
Keywords
Versions (2)
- 12/8/15 12/8/15 -
- 7/25/16 7/25/16 -
Uploaded on
December 8, 2015
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
End of Study Psoriasis MIPSO EudraCT 2014-003022-40
End of Study Psoriasis MIPSO EudraCT 2014-003022-40
- StudyEvent: ODM
Similar models
End of Study Psoriasis MIPSO EudraCT 2014-003022-40
- StudyEvent: ODM
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Patient number
Item
text
Date end of study
Item
date
CL Item
regular end of study (1)
CL Item
early study termination (2)
CL Item
Change of treatment required (1)
CL Item
Patient's request (2)
CL Item
Inclusion/exclusion criteria were injured, before initializing therapy (3)
CL Item
Inclusion/exclusion criteria were injured, after initializing therapy (4)
CL Item
Entering pregnancy (5)
CL Item
Disallowed concomitant medication required (6)
CL Item
The continued participation in the clinical trial is medically no longer justifiable (7)
CL Item
Time windows for visits could not be complied with (8)
CL Item
Lack of patient compliance (9)
CL Item
Cancelation of the entire study (10)
CL Item
other reason (11)
End of Study Reason
Item
text